ReviewBioactive materials2026
Recent advances in immunocompetent human skin-on-chip models: Construction strategies and biomedical applications.
Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human skin, as the body's largest organ and primary barrier, possesses a sophisticated immune microenvironment crucial for its defensive functions. Recent advancements in organ-on-a-chip technology have facilitated the development of biomimetic skin-on-chip models, especially in the accurate recapitulation of complex immune responses for human skin diseases. This review provides a comprehensive overview of the construction strategies and biomedical applications of immunocompetent human skin-on-chip models. We systematically detail the essential components for building these systems, encompassing cell sources, biomaterial matrices, and microfluidic fabrications. A major focus is placed on the strategic integration of key immune components, specifically immune cells such as Langerhans cells, T cells, and macrophages, as well as critical immune factors. These immunocompetent skin models serve as powerful platforms for disease modeling of inflammatory conditions like psoriasis, atopic dermatitis, and allergic contact dermatitis. Furthermore, we highlight their applications in drug development, toxicity testing, and cosmetic safety assessments. Finally, the future perspective and challenges underscoring the role of immunocompetent skin-on-chip technology in advancing precision medicine and dermatological research are discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.